Radiopharmaceuticals are a cornerstone of precision medicine, enabling clinicians to visualize disease at the molecular level while simultaneously delivering targeted radionuclide therapy to tumors and other pathological tissues. Their dual diagnostic and therapeutic potential has positioned them as a transformative modality in modern healthcare. Now, the integration of artificial intelligence (AI) is reshaping this field, streamlining everything from target identification and ligand development to image interpretation, personalized dosimetry, and adaptive treatment planning, ultimately enhancing diagnostic accuracy and therapeutic safety.
At their core, radiopharm...
